Opinion|Videos|July 23, 2024
NCCN Recommendations by PD-L1 Expression Level
A panel of experts discuss how the NCCN guideline recommendations differ for patients with and without PD-L1 expression.
Advertisement
Video content above is prompted by the following:
- How do the NCCN guideline recommendations differ for patients without PD-L1 expression (<1%) compared with those with low (1%-49%) or high (≥50%) expression?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Articles
- Linvoseltamab: A New Horizon for Relapsed Myeloma
September 17th 2025
- Rapid Therapeutic Effects Seen With a JAK Inhibitor
September 17th 2025
- SALT Scoring for Alopecia Areata
September 17th 2025
- The Potential Role of Screening for Atrial Fibrillation
September 16th 2025
- Remote Patient Monitoring and Artificial Intelligence
September 16th 2025
- Reassurance in Breast Cancer Survivorship: Adriana Olivo, NP
September 15th 2025
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Cumulative Atropine Not Associated With Increased Risk of Ocular Events in Children With Myopia
2
West Coast Health Alliance Releases First Vaccine Guidelines, Aiming to Replace CDC Recommendations
3
Hospitals in Underserved Communities Less Likely to Adopt Health Information Technology
4
Sotatercept Shows Right Heart Gains in PAH: Anjali Vaidya, MD
5